Skip to main content

Table 1 Summary of patient characteristics. Cases are labelled using nomenclature Tx-yy, where Tx indicates the grade of developed visual toxicity and yy indicates the number in the group

From: Possible association of dose rate and the development of late visual toxicity for patients with intracranial tumours treated with pencil beam scanned proton therapy

Patient

Diagnosis

I/C*

Sex

Age

Pr. dose**, GyRBE

Fx dose, GyRBE

Toxicity grade

T0-01

Meningioma, WHO Grade 2

C

F

47

55.8

1.8

0

T0-02

Meningioma, WHO Grade 1

C

F

59

50.4

1.8

0

T4-03

Mature Teratoma

I

M

34

50.4

1.8

4

T0-04

Meningioma, unspecified

C

F

47

50.4

1.8

0

T0-05

Meningioma, WHO Grade 1

C

F

66

54

1.93

0

T3-06

Meningioma, unspecified

I

F

62

50.4

1.8

3

T0-07

Meningioma, WHO Grade 1

C

M

60

50.4

1.8

0

T0-08

Meningioma, WHO Grade 1

C

M

73

50.4

1.8

0

  1. Abbreviations * C: control case; I: Index case ** Prescribed dose